These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26281902)

  • 21. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rethinking Giftedness and Gifted Education: A Proposed Direction Forward Based on Psychological Science.
    Subotnik RF; Olszewski-Kubilius P; Worrell FC
    Psychol Sci Public Interest; 2011 Jan; 12(1):3-54. PubMed ID: 26168418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studies.
    Greene T
    Methods Mol Biol; 2015; 1281():225-47. PubMed ID: 25694313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical issues in schizophrenia research: a commentary on some current concerns.
    Shore D
    Schizophr Bull; 2006 Jan; 32(1):26-9. PubMed ID: 16319376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient designs: factorial randomized trials.
    Whelan DB; Dainty K; Chahal J
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():34-8. PubMed ID: 22810445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conducting power analyses for ANOVA and ANCOVA in between-subjects designs.
    Algina J; Olejnik S
    Eval Health Prof; 2003 Sep; 26(3):288-314. PubMed ID: 12971201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size estimation: a glimpse beyond simple formulas.
    Eng J
    Radiology; 2004 Mar; 230(3):606-12. PubMed ID: 14990827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
    van der Lee JH; Wesseling J; Tanck MW; Offringa M
    J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small sample randomized clinical trial methodology using N-of-1 designs and mixed model analysis.
    Ridenour TA; Hall DL; Bost JE
    Am J Drug Alcohol Abuse; 2009; 35(4):260-6. PubMed ID: 20180679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide.
    de Bekker-Grob EW; Donkers B; Jonker MF; Stolk EA
    Patient; 2015 Oct; 8(5):373-84. PubMed ID: 25726010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
    Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
    Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analyses of cluster randomization trials. Power considerations.
    Donner A; Piaggio G; Villar J
    Eval Health Prof; 2003 Sep; 26(3):340-51. PubMed ID: 12971203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating sample size in clinical studies: basic methodological principles.
    Carneiro AV
    Rev Port Cardiol; 2003 Dec; 22(12):1513-21. PubMed ID: 15008067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small sample approach, and statistical and epidemiological aspects.
    Offringa M; van der Lee H
    Handb Exp Pharmacol; 2011; 205():181-202. PubMed ID: 21882112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design principles and statistical considerations in periodontal clinical trials.
    Koch GG; Paquette DW
    Ann Periodontol; 1997 Mar; 2(1):42-63. PubMed ID: 9151542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.